Intrinsiqq
Devyser Diagnostics AB logo

Devyser Diagnostics AB

DVYSR.XSTO

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Capkr 1.08B
EPSkr 0.92
P/E69.63
P/FCF-44.30
EV/EBITDA23.20
FCF Yield–
Div. Yield–
Net Debt/FCF1.1x
Devyser Diagnostics AB intrinsic value
52-Week Range
€4.37€10.46

Profitability & Returns

Revenue (TTM)

kr 250M

▲ +15.5% YoY

Net Income (TTM)

kr 15M

▲ +86.3% YoY

Op. Margin

9.47%

▲ +33.5pp YoY

ROIC

2.23%

▲ +13.6pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-kr 24M

▲ +51.4% YoY

Op. Cash Flow (TTM)

kr 46M

▲ +110.7% YoY

Net Debt

-kr 26M

Net Cash Position

Cash & Equiv.

kr 78M

3Y CAGR: +25.5%

Continue Research

Peers

Medical Devices · Pick stocks to compare with DVYSR.XSTO

CompareIntrinsic value
MAGLE.XSTOMagle Chemoswed Holding AB
€0.02+3000.00%15
MNTC.XSTOMentice AB
€1.36-0.37%57
BINV.XSTOBioInvent International AB
€0.23-27.20%10
CANTA.XSTOCantargia AB
€0.12-3.83%54
SEDANA.XSTOSedana Medical AB
€0.81-1.93%48
HNSA.XSTOHansa Biopharma AB
€3.48-0.97%26
PAX.XSTOPaxman AB
€6.00+8.50%39
OSSD.XSTOOssDsign AB
€0.29-2.98%40

Devyser Diagnostics AB (DVYSR.XSTO) in four numbers

Fair value (earnings)
€1.16
Price €5.81 is 402% above it.
Intrinsic Value
Quality score
44/100
Best check: revenue growth, 25.5%. Weakest: return on capital, 2.2%.
Quality
Dividend
None
No dividend in the company filings we hold.
Dividends
P/E
69.63
Price to free cash flow -44.30.
Financials

Questions about Devyser Diagnostics AB

Is Devyser Diagnostics AB (DVYSR.XSTO) overvalued?

At €5.81, Devyser Diagnostics AB's price is 402% above the €1.16 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 69.63 times earnings. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Devyser Diagnostics AB's fair value?

Intrinsiqq's calculator puts Devyser Diagnostics AB's fair value at €1.16 a share. It grows earnings per share 5% a year for 5 years, applies an exit P/E of 17.5, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of €0.87. Every input can be changed on the Intrinsic Value tab.

Is Devyser Diagnostics AB a high-quality business?

Devyser Diagnostics AB scores 44 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 7 checks computed from company filings. Its best check is revenue growth at 25.5%, and its weakest is return on capital at 2.2%. The Quality tab shows every check against its target.

Does Devyser Diagnostics AB (DVYSR.XSTO) pay a dividend?

No. Devyser Diagnostics AB (DVYSR.XSTO) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: company filings. Price: last close 6 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing DVYSR.XSTO

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.